University of Rochester, School of Medicine and Dentistry - Doctor of Medicine Duke University Hospital - Fellowship - Pulmonary Disease (Internal Medicine) Duke University Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
James D. Crapo - Englewood CO Brian J. Day - Englewood CO Polivina Jolicia F. Gauuan - Albany NY Michael P. Trova - Schenectady NY
Assignee:
Duke University - Durham NC Aeolus Pharmaceuticals, Inc. - Research Triangle Park NC
International Classification:
A61K 5104
US Classification:
514183, 514410, 540145
Abstract:
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods. Compounds of the invention include those of Formula I.
James D. Crapo - Englewood CO Brian J. Day - Englewood CO Michael P. Trova - Schenectady NY Polivina Jolicia F. Gauuan - Albany NY Douglas B. Kitchen - Schenectady NY Irwin Fridovich - Durham NC Ines Batinic-Haberle - Durham NC
Assignee:
National Jewish Medical and Research Center - Denver CO Aeolus Pharmaceuticals INC - Research Triangle Park NC Duke University - Durham NC
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
Douglas C. Wallace - Atlanta GA, US Simon Melov - Atlanta GA, US James D. Crapo - Cherry Hills Village CO, US Brian J. Day - Englewood CO, US
Assignee:
Duke University - Durham NC Emory University - Atlanta GA
International Classification:
C12Q001/34
US Classification:
435 18, 424 92
Abstract:
The present application describes methods for the testing of compounds of potential usefulness as therapeutic antioxidants and/or as therapeutic free radical scavengers. The animal model for testing such compounds is the Sod2CJE homozygous Manganese Superoxide Dismutase-deficient mouse. When pups of these mice are treated with certain antioxidants, they survive past about 7 days of age, and later develop characteristic histological changes and characteristic neurobehavioral disorders. Those treated mice can be further treated with test compounds which may or may not cross the blood brain barrier, and the life span and physical and neurobehavioral characteristics of those mice provide information about the potential utility of the test compound as a therapeutic antioxidant. Phenotypes of the treated mice allow conclusions regarding targeted areas of the brain and thus, applications to particular disorders such as Parkinsonism.
Irwin Fridovich - Durham NC, US Ines Batinic-Haberle - Durham NC, US James D. Crapo - Englewood CO, US Brian J. Day - Englewood CO, US
Assignee:
Duke University - Durham NC National Jewish Medical and Research Center - Denver CO
International Classification:
C07D487/22 A61K031/409 A61K031/555 A61P011/06
US Classification:
514183, 514184, 514185, 540145
Abstract:
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
James D. Crapo - Englewood CO, US Brian J. Day - Englewood CO, US Michael P. Trova - Schenectady NY, US Polivina Jolicia F. Gauuan - Albany NY, US Douglas B. Kitchen - Schenectady NY, US Irwin Fridovich - Durham NC, US Ines Batinic-Haberle - Durham NC, US
Assignee:
National Jewish Medical Research Center - Denver CO Duke University - Durham NC Aeolus Sciences, Inc. - Laguna Niguel CA
International Classification:
A61K 31/409
US Classification:
514185, 514365, 514383, 514397, 514406, 514410
Abstract:
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
James D. Crapo - Englewood CO, US Brian J. Day - Englewood CO, US Michael P. Trova - Schenectady NY, US Polivina Jolicia F. Gauuan - Albany NY, US Douglas B. Kitchen - Schenectady NY, US Irwin Fridovich - Durham NC, US Ines Batinic-Haberle - Durham NC, US
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
James D. Crapo - Englewood CO, US Brian J. Day - Englewood CO, US Michael P. Trova - Schenectady NY, US Douglas B. Kitchen - Schenectady NY, US Irwin Fridovich - Durham NC, US Ines Batinic-Haberle - Durham NC, US
Assignee:
Aeolus Sciences, Inc. - Mission Viejo CA National Jewish Health - Durham NC Duke University - Denver CO
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
James D. Crapo - Englewood CO, US Brian J. Day - Englewood CO, US Michael P. Trova - Schenectady NY, US Douglas B. Kitchen - Schenectady NY, US Irwin Fridovich - Durham NC, US Ines Batinic-Haberle - Durham NC, US
International Classification:
C07D 487/22 A01N 55/02
US Classification:
540145, 514185, 514410
Abstract:
The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
Biomimetix Pharmaceutical
Chief Executive Officer
Omni Bio Pharmaceutical
Chief Executive Officer
Omni Bio Pharmaceutical
Scientific Advisor
University of Colorado Health Sciences Center 1996 - 2008
Director: Graduate Program In Clinical Science
University of Colorado Health Sciences Center 1996 - 2008
Director Emeritus, Clinical Science Graduate Program
Education:
University of Rochester 1971 - 1971
Doctor of Medicine, Doctorates
Brigham Young University 1967 - 1967
Bachelors, Bachelor of Science
Skills:
Graduate Students
Interests:
Royal College of Physicians Scotland 1982 Brenda E Brady 1993 Margaret L Oury Clinical Science Graduate Program 1983 Tim D 1994 Todd C Director Edinburgh Teaching and Mentoring 1996 2008 Bowler Stockstill 2001 Elizabeth Regan Barry 2006 John Arcaroli 1998 Russell P
Biomimetix
Chief Executive Officer
Copdgene
Co-Principal Investigator
National Jewish Health 1996 - 2004
Chairman Department of Medicine
National Jewish Health 1996 - 2004
Professor of Medicine
Duke University Jul 1976 - Jun 1996
Professor of Medicine
Education:
University of Rochester 1967 - 1971
Doctor of Medicine, Doctorates, Medicine
Brigham Young University 1961 - 1967
Bachelors, Chemistry
James Crapo 1981 graduate of Timberline High School in Lacey, WA is on Classmates.com. See pictures, plan your class reunion and get caught up with James and other high school ...
James Crapo (1993-1997), Adam Charvat (2000-2004), Gregory Clark (1976-1979), Craig Shillam (1975-1979), Matt Payeur (1997-2001), Brad Cunningham (1978-1982)